10 likes | 132 Views
Cumulative incidence of primary endpoint with intensive vs. standard lipid-lowering in treatment-resistant hypertension. Atorvastatine 10 mg. 30. Atorvastatine 80 mg.
E N D
Cumulative incidence of primary endpoint with intensive vs. standard lipid-lowering in treatment-resistant hypertension Atorvastatine 10 mg 30 Atorvastatine 80 mg Primary endpoint: death from CHD, non-fatal non-procedure-related MI, resuscitation after cardiac arrest ,fatal or non-fatal stroke 20 Primary outcome (%) 10 0 0 1 2 3 4 5 Follow-up (years) Bangalore et al., Eur Heart J 2014